...
机译:没有事先进行适当的ICD治疗的初级预防患者中评估选择性植入式心脏复律除颤器发生器的需求
Department of Cardiology, Erasmus Medical Center, P.O. Box 2040, Rotterdam 3000 CA, the Netherlands;
Division of Cardiology, University Hospital Basel, Basel, Switzerland;
Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands;
Division of Cardiology, University Hospital Basel, Basel, Switzerland;
Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands;
Division of Cardiology, University Hospital Basel, Basel, Switzerland;
Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands;
Division of Cardiology, University Hospital Basel, Basel, Switzerland;
Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands;
机译:在患者替代心力衰竭患者患者替代患者的适当抗动力卡疗法的发生率最初植入除颤器,用于初步预防:Meta分析的结果
机译:将植入式心脏复律器-去纤颤器治疗区编程到较高的范围,以防止在一级预防患者中实施不适当的器械治疗:RISSY-ICD(通过增加区域减少不适当的电击)试验的结果
机译:缺血性心脏病和植入式心脏复律除颤器的死亡率以及适当预防和不适当治疗的一级预防:来自丹麦ICD登记册的数据。
机译:心室梯度的运动恢复滞后预测一级预防性ICD患者的抗心律失常治疗
机译:植入式心脏复律除颤器患者不适当电击危险因素的发生率和临床预测因素
机译:植入式心脏复律除颤器发生器更换后预防心脏猝死的结果
机译:PMD7对一级预防性植入式心脏复律除颤器患者进行首次适当治疗的时间依赖性:在没有事先ICD干预的患者中是否需要更换器械?